FNY Investment Advisers’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

FNY Investment Advisers’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,000	Closed	-$633K	–	892
2023 Q4	$633K	Buy	+2,000	New	+$389K	0.7%	35
2019 Q3	–	Sell	-811	Closed	-$16K	–	1220
2019 Q2	$16K	Buy	+811	New	+$16.2K	﹤0.01%	512

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

FNY Investment Advisers's KRTX Position: Q1 2024 in Review

FNY Investment Advisers sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,000 shares — an estimated $633K sold.

FNY Investment Advisers first reported a position in KRTX in Q2 2019 and held it in 2 quarters. The position peaked at $633K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

FNY Investment Advisers reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
FNY Investment Advisers sold 2,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $633K.
FNY Investment Advisers first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
FNY Investment Advisers's Karuna Therapeutics, Inc. Common Stock position peaked at $633K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on FNY Investment Advisers's 13F filing for Q1 2024, filed 3 May 2024.